In adults exposed to COVID-19, hydroxychloroquine did not reduce confirmed or probable COVID-19; trial stopped for futility.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 33075259.
- Also identified by DOI 10.7326/ACPJ202010200-041.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Boulware DR, Pullen MF, Bangdiwala AS, et al. <b>A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19.</b> N Engl J Med. 2020;383:517-25. 32492293.
Medical subject headings
- Coronavirus Infections
- Hydroxychloroquine
- Medical Futility
- Pandemics
- Pneumonia, Viral